Coronavirus disease 2019 in children presents with milder clinical manifestations than in
adults. On the other hand, the presence of a wide range of inflammatory manifestations …

The COVID-19 pandemic has led the world to undertake the largest vaccination campaign in
human history. In record time, unprecedented scientific and governmental efforts have …

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination —
PCORnet, United States, January 2021–January 2022 | MMWR Skip directly to site content Skip …

Background Multisystem inflammatory syndrome in children (MIS-C) is the most severe
clinical entity associated with pediatric SARS-CoV-2 infection with a putative role of the …

METHODS We analyzed data from 3 United States safety monitoring systems: v-safe, a
voluntary smartphone-based system that monitors reactions and health effects; the Vaccine …

Objective To review whether the current COVID-19 vaccines can prevent the occurrence of
multisystem inflammatory syndrome in children (MIS-C) and adolescents. Methods A …

Multisystem inflammatory syndrome in children (MIS‐C) is a rare, but severe complication of
coronavirus disease 2019 (COVID‐19). It develops approximately 4 weeks after severe …

Background Multisystem inflammatory syndrome in children (MIS-C), linked to antecedent
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is associated with …

During the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), mitigation policies for children have been a topic of considerable uncertainty and …

The development of the mutant omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) during the coronavirus disease 2019 (COVID-19) pandemic …